Four Time Winner

Exeevo Omnipresence powered by Microsoft Cloud for Healthcare is featured for the fourth time in Gartner’s Hype Cycle for Life Science Commercial Operations, 2022 report. Omnipresence was recognized as a leading life sciences solution in three categories:

  • Personalization Engine
  • Patient Engagement Hub
  • and the newly emerging area of Patient Engagement.

Life Sciences Personalization Engine

Gartner calls out Exeevo Omnipresence as an option when discussing opportunities to close gaps in the CRM tech stack with better analytics, testing, segmentation, and channel orchestration.

Life Sciences Patient Engagement Hub (PEH)

Gartner gave a nod to Omnipresence’s marketing automation that helps HCPs, health systems, and pharmacists deliver targeted patient experiences at the appropriate times to put their digital strategies into practice.

Life Sciences Key Account Management

Omnipresence scored again in this category with our solution as it incorporates a Medical Affairs CRM designed for interactions with Medical Affairs, healthcare providers (HCPs) and suitable for KAM needs. The ability to have unified data simplifies understanding organizational hierarchies, making it easy to gain favor with multiple decision-makers within a large healthcare organization.

Gartner Has Faith in Exeevo

The 2022 Hype Cycle is far from the first example of Gartner analysts identifying Exeevo as a leading customer experience management solution for LSOs.

Gartner has hyped Exeevo in the 2021 Hype Cycle™ for Life Science Commercial Operations naming Omnipresence in 3 categories. In 2020, Gartner recognized Omnipresence as a top-3 provider of Global CRM capabilities for LSOs. And another Hype Cycle report highlighted our customer experience solutions for the following:

  • Advanced Decision Support for Sales
  • Multichannel Campaign Management
  • Account Management and Selling

To learn more about the modular flexibility of Omnipresence and its ability to provide and orchestrate a true 360° view of customers to drive commercial objectives and our strategic partnership with Microsoft, visit us at